title: Antituberculous therapy and acute liver failure.
authors.forename: F
authors.initials: F
authors.lastname: Durand
authors.forename: D
authors.initials: D
authors.lastname: Pessayre
authors.forename: M
authors.initials: M
authors.lastname: Fournier
authors.forename: J
authors.initials: J
authors.lastname: Belghiti
authors.forename: S
authors.initials: S
authors.lastname: Erlinger
authors.forename: J
authors.initials: J
authors.lastname: Bernuau
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006501:Hepatic Encephalopathy / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000601:surgery; D016031:Liver Transplantation; D011718:Pyrazinamide / Q000009:adverse effects
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid